Allspring Global Investments’s Medline Inc MDLN Stock Holding History

Allspring Global Investments’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$59.7M	Buy	+1,357,563	New	+$59.9M	0.1%	239

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Allspring Global Investments's MDLN Position: Q1 2026 in Review

Allspring Global Investments opened a new position in Medline Inc (MDLN) in Q1 2026: 1,357,563 shares worth $59.7M. The stake represents 0.1% of the portfolio and ranks #239 among its holdings.

314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Allspring Global Investments held 1,357,563 shares of Medline Inc worth $59.7M as of Q1 2026.
Medline Inc was a new Allspring Global Investments position in Q1 2026.
Medline Inc made up 0.1% of Allspring Global Investments's portfolio in Q1 2026, its #239 holding.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.